To determine radiation dermatitis severity reduction by prophylactic dressing in breast cancer patients who are receiving whole breast irradiation.
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2022/08/044659
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Above 18 years of age
2. Breast-conservative surgery for breast cancer
3. A hypofractionation regimen of 40.5Gy in 15
fractions with simultaneous integrated boost
technique.
Exclusion Criteria
1. Active smoking status
2. Metastatic disease
3. Previous radiation to the ipsilateral breast
4. Flap reconstruction surgery
5. Active dermatitis
6. Any preexisting dermatological disorders
7. Treatment with topical or oral corticosteroids8. Mastectomy
9. Tattoos in the irradiation area
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the reduction in radiation dermatitis severity using CTCAE v.5 criteria, modified RISRAS and modified <br/ ><br>10-point Catterall skin scoring profile for early <br/ ><br>breast cancer patients undergoing hypofractionated simultaneous integrated boost using VMAT by prophylactic polyurethane film dressing.Timepoint: At the last fraction of radiation and 4 weeks post radiation
- Secondary Outcome Measures
Name Time Method To assess the impact of skin disease on the quality of life using Dermatology Life Quality Index (DLQI) questionnaire.Timepoint: At the last fraction of radiation and 4 weeks post radiation